Catalyst Pharmaceuticals Files 2025 DEF 14A
Ticker: CPRX · Form: DEF 14A · Filed: Apr 11, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | DEF 14A |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Catalyst Pharma's 2025 DEF 14A is out, detailing exec pay & 2024 financials. Look out for equity award info.
AI Summary
Catalyst Pharmaceuticals, Inc. filed a DEF 14A on April 11, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key financial data for the years 2022, 2023, and 2024 are presented, including information on equity awards granted to executive officers.
Why It Matters
This filing provides transparency into executive compensation and corporate governance decisions at Catalyst Pharmaceuticals, which can influence investor confidence and company strategy.
Risk Assessment
Risk Level: low — This filing is a routine annual disclosure (DEF 14A) and does not contain new material events or financial distress signals.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the filing.)
- 20250411 — Filing Date (Date the DEF 14A was submitted to the SEC.)
- 20250520 — Period of Report (The period covered by the proxy statement.)
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Filer
- 0001369568 (company) — Central Index Key
- 355 ALHAMBRA CIRCLE (address) — Business and Mail Address
- CORAL GABLES (location) — City
- FL (location) — State
- 33134 (zip_code) — Zip Code
- (305) 529-2522 (phone_number) — Business Phone
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is a proxy statement filed by a company with the SEC to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
What is the Central Index Key (CIK) for Catalyst Pharmaceuticals, Inc.?
The Central Index Key for Catalyst Pharmaceuticals, Inc. is 0001369568.
When is Catalyst Pharmaceuticals' fiscal year end?
Catalyst Pharmaceuticals' fiscal year ends on December 31.
What is the business address of Catalyst Pharmaceuticals?
The business address for Catalyst Pharmaceuticals is 355 Alhambra Circle, Suite 801, Coral Gables, FL 33134.
What type of business is Catalyst Pharmaceuticals primarily involved in?
Catalyst Pharmaceuticals, Inc. is primarily involved in Pharmaceutical Preparations, with Standard Industrial Classification code 2834.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 11, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).